Brief: Biogen To Buy Alcyone Therapeutics, Expanding Drug Delivery Solutions For Key Products and Pipeline
18/09/2025 12:54
Sept 18 (Reuters) - Biogen Inc BIIB.O: BIOGEN TO ACQUIRE ALCYONE THERAPEUTICS, EXPANDING DRUG DELIVERY SOLUTION PORTFOLIO FOR KEY PRODUCT AND PIPELINE CANDIDATES BIOGEN INC - TO BUY ALCYONE FOR $85M UPFRONT PLUS MILESTONES BIOGEN INC - PLANS SPINRAZA DELIVERY SYSTEM LAUNCH IN 2028 Source text: ID:nGNX8QD0mR Further company coverage: BIIB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ionis Pharmaceuticals
See all newsUS FDA approves GSK's hepatitis B drug, offering patients chance to stop long-term treatment (updated)
US FDA approves GSK's hepatitis B drug, offering patients chance to stop long-term treatment
Focus: AI companies run virtual drug trials, aim to improve success of human studies
Brief: Ionis Pharmaceuticals Says Ulefnersen Demonstrates Favorable Safety And Tolerability Profile
Otsuka, Ionis' experimental ALS drug meets main goal in late-stage study